Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Pulse Biosciences, Inc (PLSE) had Tangible Shareholders Equity of $114.61M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-16.80M |
|
-- |
|
-- |
|
$18.04M |
|
$-18.04M |
|
$1.25M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-18.04M |
|
$-17.76M |
|
67.13M |
|
67.13M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$120.91M |
|
$1.06M |
|
$12.47M |
|
$133.38M |
|
$7.76M |
|
-- |
|
$7.17M |
|
$14.93M |
|
$118.45M |
|
|
Tangible Shareholders Equity |
$114.61M |
$118.45M |
|
67.27M |
|
| Cash Flow Statement Financials | |
$-13.52M |
|
$-0.04M |
|
$14.81M |
|
$118.04M |
|
$119.28M |
|
$1.24M |
|
$5.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.18% |
|
-14.65% |
|
-12.59% |
|
-14.18% |
|
$1.76 |
|
$-0.20 |
|
$-0.20 |
|